Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Escitalopram Oxalate, and when can generic versions of Escitalopram Oxalate launch?

Escitalopram Oxalate is a drug marketed by Invagen Pharms, Macleods Pharms Ltd, Sti Pharma Llc, Hetero Labs Ltd Iii, Taro, Amneal Pharms, Aurobindo Pharma Ltd, Prinston Inc, Zydus Pharms Usa Inc, Torrent Pharms Ltd, Mylan Pharms Inc, Teva Pharms Usa, Hikma Pharms, Antrim Pharms Llc, Lupin Ltd, Silarx Pharms Inc, Apotex Inc, Jubilant Generics, and Accord Hlthcare. and is included in twenty-two NDAs.

The generic ingredient in ESCITALOPRAM OXALATE is escitalopram oxalate. There are twenty-five drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the escitalopram oxalate profile page.

Summary for Tradename: ESCITALOPRAM OXALATE

Suppliers / Packagers: see list53
Bulk Api Vendors: see list68
Clinical Trials: see list103
Patent Applications: see list378
Drug Prices:see details

Pharmacology for Tradename: ESCITALOPRAM OXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
escitalopram oxalate
TABLET;ORAL078169-002Sep 11, 2012ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
escitalopram oxalate
SOLUTION;ORAL079062-001Apr 2, 2012AARXNoNo► Subscribe► Subscribe
Jubilant Generics
escitalopram oxalate
TABLET;ORAL202280-003Sep 12, 2012ABRXNoNo► Subscribe► Subscribe
Apotex Inc
escitalopram oxalate
TABLET;ORAL078777-002Sep 11, 2012ABRXNoNo► Subscribe► Subscribe
Accord Hlthcare
escitalopram oxalate
TABLET;ORAL202389-001Sep 11, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus